Biotech entity
Of the tracked stories, 1 of 2 also mention Center for Biological Diversity, the most common co-covered peer. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. The tracked stories average 6 original sources each.
Last mentioned: Sep 5, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Of the tracked stories, 1 of 2 also mention Center for Biological Diversity, the most common co-covered peer. The clearest coverage concentration is fda-approval: 1 of 2 stories, with the rest divided among 1 other category. The tracked stories average 6 original sources each. Doug Burgum appears in 2 tracked Biotech stories published from July 18, 2026 through July 20, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 8 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Doug Burgum. Shared-story counts are live from our verified record — not editorial picks.
The Trump administration’s rollback of Endangered Species Act protections could accelerate habitat loss for over 1,600 listed species, raising concerns in the biotech sector about the loss of undiscovered natural compounds critical for drug development.
Source: redmond-reporter.com · bothell-reporter.com
The U.S. Interior Department’s cancellation of automatic ESA protections for threatened species could accelerate biodiversity loss, directly threatening the natural sources of many pharmaceuticals. Bioprospecting and natural product R&D face heightened uncertainty as habitat destruction outpaces species discovery. The rule change adds regulatory complexity for biotech companies seeking access to rare organisms.
Doug Burgum is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
